Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 35,004,590 cases with around 613,220 deaths. India confirmed a total of at least 31,695,950 cases and 424,770 deaths, while Brazil reported over 19,938,350 COVID-19 cases with 556,830 deaths. In total, there were at least 198,392,550 cases of COVID-19 worldwide with more than 4,225,600 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Consumer discretionary shares climbed 0.6% on Monday. Meanwhile, top gainers in the sector included Arcimoto, Inc. FUV, up 7% and Envela Corporation ELA up 5%.
In trading on Monday, materials shares fell 0.9%.
Global Payments Inc. GPN reported better-than-expected results for its second quarter and raised its FY21 guidance.
Global Payments reported quarterly earnings of $2.04 per share, beating analysts’ estimates of $1.89 per share. The company’s adjusted net revenue came in at $1.94 billion, surpassing analysts’ expectations of $1.85 billion.
Global Payments said it now expects FY21 EPS of $8.07-$8.20 versus prior forecast of $7.87-$8.07. The company also boosted its adjusted net revenue guidance from $7.55 billion-$7.625 billion to $7.70 billion -$7.73 billion. The company also added $1.5 billion to its buyback program
Equities Trading UP
Ever-Glory International Group, Inc. EVK shares shot up 143% to $5.48 after the company announced a $5 million stock repurchase program.
Shares of Infinity Pharmaceuticals, Inc. INFI got a boost, shooting 37% to $2.90. JP Morgan upgraded Infinity Pharmaceuticals from Neutral to Overweight and announced a $6 price target.
Exicure, Inc. XCUR shares were also up, gaining 35% to $1.82. Ipsen and Exicure have collaborated to research, develop, and commercialize novel Spherical Nucleic Acids (SNAs) as potential investigational treatments for Huntington's disease and Angelman syndrome.
Equities Trading DOWN
Immunovant, Inc. IMVT shares tumbled 24% to $7.96 after the company received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in multiple indications.
Shares of TG Therapeutics, Inc. TGTX were down 21% to $27.51 after the company posted a wider-than-expected quarterly loss.
Marin Software Incorporated MRIN was down, falling 14% to $7.09 after the company reported an adjusted loss of $0.21 per share for the second quarter, versus a year-ago loss of $0.36 per share. Its net revenues dropped 16% year-over-year to $6.1 million.
In commodity news, oil traded down 3.8% to $71.17, while gold traded up 0.2% to $1,820.50.
Silver traded down 0.1% Monday to $25.545 while copper fell 1.3% to $4.4240.
European shares closed mostly higher today. The eurozone’s STOXX 600 surged 0.59%, the Spanish Ibex Index rose 0.96% and the German DAX 30 gained 0.16%. Meanwhile, the London’s FTSE 100 gained 0.7%, French CAC 40 climbed 0.95% and Italy’s FTSE MIB slipped 0.05%.
The IHS Markit Eurozone manufacturing PMI rose to 62.8 in July from a preliminary reading of 62.6, but down from June’s reading of 63.4. The IHS Markit/CIPS UK manufacturing PMI declined to 60.4 in July from 63.9 in the earlier month
Retail sales in Germany surged 4.2% in June following a 4.6% growth in May, while manufacturing PMI was revised higher to 65.9 in July from a preliminary reading of 65.6. French manufacturing PMI declined to 58 in July from 59 in the previous month, while Italy’s manufacturing PMI slipped to 60.3 from 62.2. The IHS Markit Spain’s manufacturing PMI declined to 59 in July versus June’s reading of 60.4, while consumer confidence indicator fell by 5.5 points to 91.9 in July.
The IHS Markit manufacturing PMI was revised higher to 63.4 in July from a preliminary reading of 63.
The ISM manufacturing PMI dropped to 59.5 in July from 60.6 in June.
US construction spending rose 0.1% for June.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.